LISINOPRIL

Product NDC: 51655-402
11-digit product format: 516550402
Labeler code: 51655
Product ID: 51655-402_765927a0-c165-4e9d-ab40-051d41b03a9d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LISINOPRIL
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Pharmaceuticals, LLC
Application: ANDA075994
Marketing category: ANDA
Marketing start: 2014-11-17
Marketing end: 0000-00-00
Substance: LISINOPRIL
Active strength: 10 1/1
Pharmacologic classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-402-26	2026-01-13	C162847	48780-1	9d75b9d0-39f7-f424-e053-dadaa90a57ce	fdd82e9a-f51b-4743-8c63-21973726caec
51655-402-26	2020-01-31	C162847	48780-1	9d75b9d0-39f7-f424-e053-dadaa90a57ce	fdd82e9a-f51b-4743-8c63-21973726caec

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1
LISINOPRIL ANHYDROUS	ACTIVE MOIETY	7Q3P4BS2FD	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-402	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1	Legacy NDC	20141119_fdd82e9a-f51b-4743-8c63-21973726caec.zip